Literature DB >> 18379152

Extreme hyperphosphatemia and hypocalcemic coma associated with phosphate enema.

Heng Jung Hsu1, Mai-Szu Wu.   

Abstract

Fleet enema (sodium phosphate, C.B. Fleet Co., Inc., Lynchburg, Virginia) is widely used for bowel preparation or constipation relief in the hospital and over the counter. The potential risks, including hyperphosphatemia and hypocalcemic coma should be kept in mind of primary care physician. The patients with older age, bowel obstruction, small intestinal disorders, poor gut motility, and renal disease are contraindicated or should be administered with caution. We present a patient with old age and chronic renal failure who developed severe hyperphosphatemia and hypocalcemic tetany with coma after sodium phosphate enema. We recommend the use of alternative enema preparations, such as simple tap water or saline solution enemas, which can prevent fatal complications in high risk patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379152     DOI: 10.2169/internalmedicine.47.0704

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Preoperative evaluation and risk management.

Authors:  David P Parsons
Journal:  Clin Colon Rectal Surg       Date:  2009-02

2.  Flow-through peritoneal dialysis in neonatal enema-induced hyperphosphatemia.

Authors:  Dusan Kostic; Andre Broggin Dutra Rodrigues; Antônio Leal; Camila Metran; Meire Nagaiassu; Andréia Watanabe; Maria Esther Ceccon; Uenis Tannuri; Vera Hermina Koch
Journal:  Pediatr Nephrol       Date:  2010-06-06       Impact factor: 3.714

3.  [Pharmacological treatment of constipation].

Authors:  S Müller-Lissner
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

4.  Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema.

Authors:  Carolina Gracia-Iguacel; Emilio Gonzalez-Parra; Laura Rodriguez-Osorio; Ana Belén Sanz; Yolanda Almaden; Concepcion de la Piedra; Jesus Egido; Mariano Rodriguez; Alberto Ortiz
Journal:  J Bone Miner Metab       Date:  2013-05-16       Impact factor: 2.626

5.  Phosphate induced crystal acute kidney injury - an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: case report and review of the literature.

Authors:  S Lochy; R Jacobs; P M Honoré; E De Waele; O Joannes-Boyau; J De Regt; V Van Gorp; H D Spapen
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-03-16

6.  The impact of phosphate-balanced crystalloid infusion on acid-base homeostasis (PALANCE study): study protocol for a randomized controlled trial.

Authors:  Judith-Irina Pagel; Nikolai Hulde; Tobias Kammerer; Michaela Schwarz; Daniel Chappell; Alexander Burges; Klaus Hofmann-Kiefer; Markus Rehm
Journal:  Trials       Date:  2017-07-10       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.